Early-Stage Alpha — Waiting List Open

Clinical-grade pedigree analysis,
finally in your browser

Evagene unifies pedigree drawing, clinical data modelling, and Bayesian risk analysis in a single platform. Standard ISCN/HGNC notation. Integrated BayesMendel engine (BRCAPRO, MMRpro, PancPRO). A 184-disease catalog with ICD-10 and OMIM codes. Zero installs.

Standard pedigree notation (ISCN/HGNC) Per-individual consent-to-share flags No installation required
BayesMendel R engine (peer-reviewed) ICD-10 & OMIM coded
evagene.net/pedigree/brca-family
Three-generation BRCA pedigree with standard genetic notation and integrated BRCAPRO risk results
184 Diseases
6 Risk Models
The Problem

Existing pedigree tools cost clinicians time, not save it

Paper charts get lost in handover. General-purpose diagramming tools don't understand affection fill or proband arrows. Legacy genetics software forces you to re-key family data into a separate BayesMendel calculator — and none of it runs in a browser.

The result: consultation time wasted on tools rather than patients. Incompatible exports between research teams. Families locked out of their own history.

Evagene

Draw. Annotate. Analyse. Export. One tab.

Evagene combines gesture-based pedigree drawing, deep clinical data modelling, Bayesian risk analysis, and universal data exchange — in a single browser application with no installation.

Draw a circle for a female. A square for a male. Connect them. Add diseases with ICD-10 codes. Run BRCAPRO. Export to PDF. That is the entire workflow.

Explore capabilities

A complete pedigree platform, not another drawing tool

From gesture-based canvas drawing to Bayesian cancer risk models and GEDCOM interoperability — clinical-grade power in an interface anyone can learn in minutes.

Gesture Drawing

Freehand-draw circles, squares, and diamonds on the HTML5 canvas. Draw lines to form relationships. Natural as pen and paper, with keyboard accelerators.

MFUPshortcuts

ISCN/HGNC Notation

Internationally recognised pedigree symbols: affection fill, carrier dots, half-fill, mortality overlays, consanguinity double-lines, proband arrows, and fertility indicators.

Rich Properties Editor

Floating draggable panel: identity (8 biological sex options), death status (12 options), lifestyle, contact fields, consent-to-share flags, relationship events — all synced in real time.

184-Disease Catalog

Oncology, cardiology, neurology, metabolic — each entry carries ICD-10, OMIM, inheritance pattern, penetrance tables, and carrier frequencies by ethnicity.

Bayesian Risk Models

BRCAPRO, MMRpro, PancPRO via the peer-reviewed BayesMendel engine. Plus autosomal dominant/recessive and X-linked Mendelian models with age-dependent penetrance.

Interactive Karyogram

Ideogram of all chromosomes with genetic markers at genomic positions, colour-coded by test result (positive / VUS / negative), with centromere bands.

Broad Data Exchange

Import JSON, GEDCOM 5.5.1, XEG, 23andMe, and images (OCR). Export to JSON, GEDCOM, PNG (up to 4x), SVG, and PDF (A4/A3/Letter/Legal).

Consanguinity & Kinship

Wright's path coefficient calculates consanguinity coefficients automatically. Values display on relationship lines and feed directly into risk models.

Advanced Search

Query builder: filter by sex, disease status, age, tests, treatments — across parents, siblings, ancestors, descendants. AND/OR modes. Results highlighted on canvas.

Batch Investigation

Screen a proband across multiple diseases simultaneously. Generate dual-audience reports: one written for the patient, one for the clinical geneticist.

Allergies & Traits

59 allergies (severity, IgE, cross-reactivity). 51 traits (heritability, marker associations). Enables genotype-phenotype correlation in a unified model.

Auto-Layout & UX

Algorithm-based positioning respecting family structure. Undo/redo, copy/paste, lasso select, snap-to-grid, pinch zoom, light/dark theme, configurable fonts.

Ready to draw your first pedigree?

Request Alpha Access

Purpose-built for every user who works with pedigrees

From specialist geneticists to patients documenting family history — Evagene adapts to your workflow and expertise level.

Replace paper charts and workarounds with a purpose-built system

Every symbol, fill pattern, and overlay follows standard clinical pedigree conventions — eliminating the ambiguity of hand-drawn charts and the limitations of diagramming tools.

  • Run BRCAPRO, MMRpro, PancPRO, and Mendelian risk models directly from the pedigree — no re-entering data
  • 184 diseases pre-configured with ICD-10, OMIM, inheritance patterns, penetrance data, and ethnicity-specific carrier frequencies
  • Batch investigation: screen a proband across multiple conditions with structured dual-audience reports
  • Linkage analysis: LOD scores, flanking markers, haplotype tables, Haldane/Kosambi map functions
Pedigree canvas + risk panel
CanvasRisk PanelRisk by age table
Major Differentiator

Integrated BayesMendel risk analysis — no second tool needed

The BayesMendel R engine runs as a sidecar process. Select a proband, choose a model, click Run Analysis. Carrier probabilities and age-specific risk tables appear in the same panel — no copy-paste, no data re-entry.

BRCAPRO

Breast & Ovarian Cancer

BRCA1/BRCA2 carrier probability. Cumulative breast and ovarian cancer risk at ages 40, 50, 60, 70, 80.

Populations: General, Ashkenazi Jewish, Italian
Carrier ≥10% → clinically actionable
Carrier ≥25% → strongly suggestive
MMRpro

Lynch Syndrome

MLH1/MSH2/MSH6 carrier probability. Colorectal and endometrial cancer risk by age. ~3% of all CRC.

Supports Amsterdam II criteria context
Carrier ≥5% → consider IHC/MSI testing
PancPRO

Pancreatic Cancer

Pancreatic cancer susceptibility. FPC families face 5–30× general-population risk.

Genes: PALB2 and others
Lifetime risk >5% → consider EUS/MRI screening

See it in action: simulated BRCAPRO output

Select a family scenario below to see how carrier probabilities and risk change with family history.

BRCA1 carrier probability2.1%
BRCA2 carrier probability1.4%
Breast cancer risk by age 7014.2%

Below clinical action threshold. General-population screening applies.

Mendelian Inheritance Models

Built-in models for autosomal dominant, autosomal recessive, and X-linked recessive. Advanced parameters:

Age-dependent penetranceGermline mosaicismDe novo mutation ratesAnticipation (trinucleotide)Parent-of-origin biasLocus heterogeneityLinkage disequilibriumLOD scores
6
Risk models
184
Diseases catalogued
2
Report audiences

Speaks every format your workflow demands

Import from clinical systems, genealogy platforms, and consumer genomics. Export publication-ready output in any format.

FormatImportExportNotes
JSONFull snapshot; replace or add mode
GEDCOM 5.5.1Ancestry, FamilySearch, Gramps compatible
XEGLegacy Evagene v1 XML migration
23andMeGenotype, ancestry, DNA relatives, phenotype
ImageOCR + shape detection from chart photos
PNG1x–4x scale, optional transparency
SVGVector for publication-quality output
PDFA4/A3/Letter/Legal, portrait/landscape/auto

200+ built-in guides, from beginner to expert

Every disease name, genetic marker, and risk result in Evagene links directly to its guide. The help system doubles as a comprehensive genetics education resource.

184
Disease-specific guides
8
Role-specific workflows
3
Genetics knowledge levels
6
Risk model explainers

Covers the central dogma (DNA → RNA → protein), chromosome structure, Mendelian inheritance patterns, and how mutations lead to disease. Written for readers with no prior genetics background. Includes diagrams of DNA replication, meiosis, and autosomal vs. X-linked inheritance.

BRCAPRO uses Bayesian updating with the BayesMendel R package to estimate BRCA1/BRCA2 carrier probability from family pedigree data. Supports General, Ashkenazi Jewish, and Italian population frequencies. Carrier probability ≥10% is considered clinically actionable; ≥25% is strongly suggestive of hereditary breast and ovarian cancer syndrome.

ICD-10: C50. OMIM: 114480. Inheritance: multifactorial with high-penetrance genes (BRCA1, BRCA2, TP53, PALB2). Lifetime risk ~12% general population; up to 72% for BRCA1 carriers. Evagene tracks laterality, ER/PR/HER2 status, grade, stage, and age at diagnosis per individual.

M/F/U to add individuals, P for partner, D for disease palette, N for notes, G for genetics panel. Ctrl+Z/Y for undo/redo, Ctrl+C/V for copy/paste, Ctrl+A to select all, F2 to edit name, Delete to remove. Space+drag to pan, scroll to zoom, Ctrl+G for snap-to-grid.

Alpha Access

Join the Alpha waiting list

Be among the first to use Evagene. Alpha members receive early access, direct input on the roadmap, and priority support from the development team.

We will never share your information. Unsubscribe at any time.

Alpha spots are limited

Join clinicians, researchers, and families already on the waiting list. Early members shape the roadmap and receive priority support.

Request Alpha Access